Raymond James Financial
PJP icon

Raymond James Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Raymond James Financial’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Sell
23,006
-24,703
-52% -$2.67M ﹤0.01% 3257
2026
Q1 		$4.95M Buy
47,709
+35,311
+285% +$3.73M ﹤0.01% 2597
2025
Q4 		$1.3M Buy
12,398
+2,304
+23% +$232K ﹤0.01% 3611
2025
Q3 		$934K Buy
10,094
+80
+0.8% +$7K ﹤0.01% 3729
2025
Q2 		$800K Sell
10,014
-292
-3% -$23.3K ﹤0.01% 3715
2025
Q1 		$893K Sell
10,306
-1,109
-10% -$94.5K ﹤0.01% 3577
2024
Q4 		$943K Buy
+11,415
New +$982K ﹤0.01% 3489

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Raymond James Financial's PJP Position: Q2 2026 in Review

Raymond James Financial reduced its Invesco Pharmaceuticals ETF (PJP) stake by 52% in Q2 2026, selling an estimated $2.67M and leaving 23,006 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3257.

Raymond James Financial first reported a position in PJP in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.95M in Q1 2026. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Raymond James Financial held 23,006 shares of Invesco Pharmaceuticals ETF worth $2.73M as of Q2 2026.
  • Raymond James Financial sold 24,703 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $2.67M.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3257 holding.
  • Raymond James Financial first reported a position in Invesco Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Invesco Pharmaceuticals ETF position peaked at $4.95M in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.